Approval · Notice of Compliance 8776 · 2007
CLAFORAN: Notice of Compliance 8776
Issued May 9, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8776
- Date
- May 9, 2007
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revised product monograph - correction to information for pediatric patients
- Therapeutic class
- Antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CLAFORAN | Not yet assigned | — |
Medicinal ingredients
- CEFOTAXIME SODIUM 500 MG per VIAL
- CEFOTAXIME SODIUM 1 G per VIAL
- CEFOTAXIME SODIUM 2 G per VIAL